Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Total 13F shares
-
87,735,817
-
Share change
-
-7,430,742
-
Total reported value
-
$12,964,369,891
-
Put/Call ratio
-
73%
-
Price per share
-
$147.87
-
Number of holders
-
648
-
Value change
-
-$1,617,256,395
-
Number of buys
-
291
-
Number of sells
-
374
Institutional Holders of RESMED INC - Common Stock (RMD) as of Q3 2023
As of 30 Sep 2023,
RESMED INC - Common Stock (RMD) was held by
648 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
87,735,817 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Invesco Ltd., CITADEL ADVISORS LLC, NORTHERN TRUST CORP, and NORGES BANK.
This page lists
648
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.